Measures of explained variation for a regression model used in survival analysis

Journal of Medical Systems

Volumn 21, Issue 4, 1997, Pages 229-238

  Akazawa, Kouhei ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Clinical trial; Explained variation; Regression model; Survival analysis

Indexed keywords

ANTINEOPLASTIC AGENT; KRESTIN; MITOMYCIN C; PICIBANIL; TEGAFUR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL MODEL; STOMACH CANCER; SURVIVAL TIME; SYSTEM ANALYSIS;

AGE FACTORS; ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FORECASTING; HUMANS; JAPAN; LINEAR MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; RESEARCH DESIGN; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031459517     PISSN: 01485598     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022884504683     Document Type: Article

References (21)

1. Korn, E. L., & Simon, R., Measures of explained variation for survival. Stat. Med. 9: 487-503, 1990.
2. Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A., A regression modelling strategies for improve prognostic prediction. Stat. Med. 3: 143-152, 1984.
3. Kent, J. T., & O'Quigley, J., Measures of dependence for censored survival data. Biometrika 75: 525-534, 1988.
4. Hasnaoui, A. E., & Jais, J. P., Study and applications of an informational measure of dependence in survival models. Methods Inf. Med. 31: 275-283, 1992.
5. Heller, G., & Simonoff, J. S., Prediction in censored survival data: A comparison of the proportional hazards and linear regression models. Biometrics 48: 101-115, 1992.
6. Schemper, M., The explained variation in proportional hazards regression. Biometrika 77: 216-218, 1990.
7. Schemper, M., Further results on the explained variation in proportional hazards regression. Biometrika 79: 202-204, 1992.
8. Schemper, M., The relative importance of prognostic factors in studies of survival. Stat. Med. 12: 2377-2382, 1993.
9. Henderson, R., Problems and prediction in survival-data analysis. Stat. Med. 14: 161-184, 1995.
10. Link, C. L., Confidence intervals for the survival function using Cox's proportional-hazards model with covariates. Biometrics 40: 601-610, 1984.
11. Nagelkerke, N. J. D., A note on a general definition of the coefficient of determination. Biometrika 78: 691-692, 1991.
12. Simon, R., Importance of prognostic factors in cancer clinical trials. Cancer Treat. Rep. 68: 185-192, 1984.
13. Sather, H., The use of prognostic factors in clinical trials. Cancer 58: 461-467, 1986.
14. Ishida, T., Kaneko, S., Akazawa, K., et al., Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res. 53: 5000-5003, 1993.
15. Schumacher, M., Olschewski, M., & Schmoor, C., The impact of heterogeneity on the comparison of survival times. Stat. Med. 6: 773-784, 1987.
16. Hattori, T., Nakajima, T., Nakazato, H., et al., Postoperative adjuvant immunochemotherapy with Mitomycin C, Tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy. Jpn. J. Surg. 20: 127-136, 1990.
17. Inokuchi, K. (Ed.), Reports of the Special Study Project 1 (in Japanese), Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, 1992.
18. Akazawa, K., Nakamura, T., & Palesch, Y., Power of logrank test and Cox regression model in clinical trials with heterogeneous samples. Stat. Med. 16: 583-597, 1997.
19. Japanese Research Society for Gastric Cancer. The General Rules for the Gastric Cancer Study in Surgery and Pathology. Part I. Clinical classification. Jpn. J. Surg. 11: 140-145, 1981.
20. Dixon, W. J., Brown, M. B., Engelmen, L., & Jennrich, R. L., BMDP Statistical Software, University of California Press, pp. 769-806, 1990.
21. D'Agnano, I., D'Angelo, C., Savarese, A., et al., DNA ploidy proliferative index, and epidermal growth factor receptor expression and prognosis in patients with gastric cancers. Lab. Invest. 72: 432-438, 1995.